Literature DB >> 13549643

Inhibition of tuberculin skin hypersensitivity in guinea pigs by injection of tuberculin and intact tubercle bacilli during fetal life.

D W WEISS.   

Abstract

FEMALE GUINEA PIGS WERE SUBJECTED TO LAPAROTOMY AT DIFFERENT STAGES OF PREGNANCY, AND THEIR FETUSES INJECTED THROUGH THE UTERINE WALLS WITH ONE OF THE FOLLOWING PREPARATIONS: Old Tuberculin, tubercle bacilli of the BCG strain killed by heat or exposure to phenol, and living BCG. A large number of the animals injected in utero with Old Tuberculin failed to develop skin hypersensitivity to P.P.D. following vaccination with 200 or 800 gamma phenol-killed tubercle bacilli (BCG) in early adulthood. Normal control animals were sensitized by vaccination with such quantities of phenolized BCG. The failure of animals which had been injected with Old Tuberculin in fetal life to respond hypersensitively to P.P.D. after adult vaccination with tubercle bacilli is ascribed to their acquisition of a state of immunological tolerance to tuberculoprotein (tuberculin tolerance). Fetal injection with killed BCG conferred a state of tolerance on a few of the animals, and rendered others tuberculin-sensitive. Fetal injection with living BCG sensitized most of the animals to tuberculin, even when fetal exposure was as early as 46 days before birth, and induced tolerance in none. Fetuses of the same litter, injected simultaneously with identical inocula, often responded differently, some becoming tolerant to tuberculin, others developing hypersensitivity, and still others remaining immunologically unaffected, becoming neither sensitive nor tolerant. The state of tuberculin tolerance induced in these experiments was limited. When tolerant animals were revaccinated with living BCG several weeks after vaccination with phenol-killed bacilli, they developed as high a degree of tuberculin skin sensitivity as the originally non-tolerant animals.

Entities:  

Keywords:  TUBERCULIN REACTION; TUBERCULIN/effects

Mesh:

Substances:

Year:  1958        PMID: 13549643      PMCID: PMC2136884          DOI: 10.1084/jem.108.1.83

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  Acquired immune tolerance to human albumin and the response to subsequent injections of diazo human albumin.

Authors:  B CINADER; J M DUBERT
Journal:  Br J Exp Pathol       Date:  1955-10

2.  [Heterologous transplantation of tumors in pretreatment of the recipient animals with tissue from donor animals during embryonic period].

Authors:  W BOLLAG
Journal:  Experientia       Date:  1955-06-15

3.  Antibody production in avian embryos and young chicks.

Authors:  A BUXTON
Journal:  J Gen Microbiol       Date:  1954-06

4.  Passively and actively acquired antibodies for Trichomonas foetus in very young calves.

Authors:  W R KERR; M ROBERTSON
Journal:  J Hyg (Lond)       Date:  1954-06

5.  Factors influencing the survival of successful skin homografts in the chicken. I. Effects of varying age of donor and recipient.

Authors:  J A CANNON; R A WEBER; W P LONGMIRE
Journal:  Ann Surg       Date:  1954-04       Impact factor: 12.969

6.  Erythrocyte mosaicism in a pair of sheep twins.

Authors:  C STORMONT; W C WEIR; L L LANE
Journal:  Science       Date:  1953-12-04       Impact factor: 47.728

7.  Actively acquired tolerance of foreign cells.

Authors:  R E BILLINGHAM; L BRENT; P B MEDAWAR
Journal:  Nature       Date:  1953-10-03       Impact factor: 49.962

8.  A human blood-group chimera.

Authors:  I DUNSFORD; C C BOWLEY; A M HUTCHISON; J S THOMPSON; R SANGER; R R RACE
Journal:  Br Med J       Date:  1953-07-11

9.  Transplantation of normal embryonic tissues.

Authors:  M E RAWLES
Journal:  Ann N Y Acad Sci       Date:  1952-08-08       Impact factor: 5.691

10.  VIRULENCE AND MORPHOLOGICAL CHARACTERISTICS OF MAMMALIAN TUBERCLE BACILLI.

Authors:  G Middlebrook; R J Dubos; C Pierce
Journal:  J Exp Med       Date:  1947-07-31       Impact factor: 14.307

View more
  10 in total

1.  STUDIES ON THE SUPPRESSION OF IMMUNE RESPONSES BY THE PERIWINKLE ALKALOIDS VINCRISTINE AND VINBLASTINE.

Authors:  A C AISENBERG; B WILES
Journal:  J Clin Invest       Date:  1964-12       Impact factor: 14.808

2.  The effect of pre- and neonatally injected diphtheria toxoid on the homologous responsiveness of young guinea pigs. A preliminary report.

Authors:  D W WEISS
Journal:  Immunology       Date:  1962-03       Impact factor: 7.397

3.  Immunological unresponsiveness in guinea pigs. II. The effect of unresponsiveness on the development of delayed type hypersensitivity to protein antigens.

Authors:  J L TURK; J H HUMPHREY
Journal:  Immunology       Date:  1961-10       Impact factor: 7.397

4.  Attempted induction of immunological tolerance in rabbits using living Treponema pallidum.

Authors:  H FESTENSTEIN; V BOKKENHEUSER
Journal:  Br J Exp Pathol       Date:  1961-04

5.  Development of immunity to tuberculosis in adult mice injected with tubercle bacilli during foetal life.

Authors:  R J REES; E W GARBUTT
Journal:  Immunology       Date:  1961-01       Impact factor: 7.397

6.  Maturation of mitogenic response in foetal guinea-pig.

Authors:  J Merikanto
Journal:  Immunology       Date:  1979-12       Impact factor: 7.397

7.  Experimental production of pulmonary granulomas; II. Age dependency and immune modulation of granuloma production.

Authors:  Y Hamamoto; K Kinoshita; K Hashimoto; T Matsushita; K Yasuhira
Journal:  Br J Exp Pathol       Date:  1982-10

8.  Hypersensitivity in newborn guinea pigs.

Authors:  S B SALVIN; M B GREGG; R F SMITH
Journal:  J Exp Med       Date:  1962-04-01       Impact factor: 14.307

9.  THE SPECIFICITY OF ALLERGIC REACTIONS. VII. IMMUNOLOGIC UNRESPONSIVENSSS, DELAYED HYPERSENSITIVITY, AND CIRCULATING ANTIBODY TO PROTEINS AND HAPTEN-PROTEIN CONJUGATES IN ADULT GUINEA PIGS.

Authors:  S B SALVIN; R F SMITH
Journal:  J Exp Med       Date:  1964-05-01       Impact factor: 14.307

10.  Inhibition of the lesions of primary vaccinia and of delayed hypersensitivity through immunological tolerance in rabbits.

Authors:  J A FLICK; W B PINCUS
Journal:  J Exp Med       Date:  1963-04-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.